ERDERA Learning Portal

The ERDERA Learning Portal brings together courses and resources for researchers, clinicians, patient representatives, policymakers, and industry professionals, suited to different levels of knowledge. Some of the training and resources presented are developed or endorsed by ERDERA, while others are provided by external organisations and are not ERDERA training. By supporting skills development, encouraging collaboration, and facilitating knowledge exchange, ERDERA helps connect people and expertise across the rare disease research community.

ERDERA TRAINING

Course is erdera

TYPE

Course type

LEVEL

course level

STATUS

course status

LENGTH

Course lenght

COST

Course Cost

CERTIFICATION

Course certification

CATEGORY

course category

TAG CLOUD

Select some options
Course Tag

Contact the Training & Education Work Stream. Please note that you will leave the ERDERA environment

Workshop

2nd ERDERA Training for Young Advocates for Rare Diseases

This training aims to empower young patients by providing them with the knowledge, confidence and skills needed to actively take part in paediatric and rare disease research.
workshop
•
basic
Workshop

Biomarker Commercialization Toolset

This website offers a set of free biomarker commercialization tools to help researchers, small and medium sized companies (SMEs), and technology transfer offices (TTOs) tackle the highly regulated and interdisciplinary landscape of in-vitro diagnostics applicable biomarkers, i.e., markers intended to provide information on the health status of a person.
workshop
•
basic
Workshop

Cell and gene therapy for rare diseases

A 5-day course offering an end-to-end translational overview, from discovery through manufacturing and regulation, to reimbursement and patient access
workshop
•
intermediate
E-Learning

Clinical development

Clinical trials test whether a repurposed drug is safe and effective for a new indication.
e-learning
•
basic
E-Learning

Collaborations

Effective collaboration is essential for any project involving several Stakeholders.
e-learning
•
basic

Composite endpoints including patient relevant endpoints (Quality of Life)

webinar
•
advanced

Current research services available for the rare diseases community

webinar
•
basic

Definition of orphan drug by the EMA

The so-called ‘orphan drugs’ are intended to treat diseases so rare that sponsors are reluctant to develop them under usual marketing conditions.
webinar
•
intermediate
E-Learning

Design and Interpretation of Clinical Trials

Clinical trials are structured experiments used to assess new treatments in humans. Randomised designs provide the most reliable evidence by ensuring objective, unbiased evaluation of benefits and risks. This course introduces key concepts in trial design, reporting, analysis, and the ethical foundations of research involving human participants.
e-learning
•
basic

Designing and conducting clinical trials in rare diseases

What industries expect for partnering with clinical sites
webinar
•
basic
Mooc

Diagnosing Rare Diseases: from Clinic to research and back

Discover the role of research, clinical investigation and data sharing in diagnosing rare diseases.
mooc
•
basic

Does Randomization matter in clinical trials?

webinar
•
advanced

Educational Webinar 2 “Practical guide on how to use the Catalogue of services and the IMT”

webinar
•
basic
Multi Format

EJP- RD Orphanet Training Sessions

Orphanet Nomenclature of Rare Diseases
multi-format
•
basic

ERDERA Ethics and Regulatory webinar series, session 4: Ethics & Artificial Intelligence in Scientific Research

This webinar provides an overview of the ethical issues associated with using artificial intelligence in scientific research, particularly in rare diseases, and introduces the concept of trustworthy AI as reflected in key ethics guidelines.
webinar
•
intermediate

ERDERA Ethics and Regulatory webinar series, session3: Ethics & Artificial Intelligence in Scientific Research

This webinar introduces the ethical concerns raised by using artificial intelligence in scientific research, with a focus on rare diseases and on the guidelines that help ensure AI tools are trustworthy.
webinar
•
intermediate